Form 4 CURALEAF HOLDINGS For: 6 October
- Investing.com
Metrics to compare | CURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −56.7x | −2.0x | −0.3x | |
PEG Ratio | −0.67 | −0.02 | 0.00 | |
Price/Book | 2.7x | 0.7x | 2.6x | |
Price / LTM Sales | 1.8x | 1.2x | 2.9x | |
Upside (Analyst Target) | 55.9% | 166.8% | 63.9% | |
Fair Value Upside | Unlock | 22.6% | 9.4% | Unlock |
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.